Cargando…
Immunogenicity of botulinum toxins
Botulinum neurotoxins are formulated biologic pharmaceuticals used therapeutically to treat a wide variety of chronic conditions, with varying governmental approvals by country. Some of these disorders include cervical dystonia, post-stroke spasticity, blepharospasm, migraine, and hyperhidrosis. Bot...
Autores principales: | Naumann, Markus, Boo, Lee Ming, Ackerman, Alan H., Gallagher, Conor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555308/ https://www.ncbi.nlm.nih.gov/pubmed/23008029 http://dx.doi.org/10.1007/s00702-012-0893-9 |
Ejemplares similares
-
Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022) -
Immunogenicity Associated with Botulinum Toxin Treatment
por: Bellows, Steven, et al.
Publicado: (2019) -
Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
por: Carr, Warner W., et al.
Publicado: (2021) -
Clinical Relevance of Botulinum Toxin Immunogenicity
por: Benecke, Reiner
Publicado: (2012) -
Comments on Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
por: Foster, Keith, et al.
Publicado: (2020)